Overview

Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
In order to evaluate the effect of eliminating nasal carriage by mupirocin prophylaxis on subsequent Staphylococcus aureus infection, a prospective randomized trial was performed particularly including patients with predisposing risk factors for S. aureus infections.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital Muenster
Collaborator:
GlaxoSmithKline
Treatments:
Mupirocin